New combo offers hope for kids with resistant cancers
NCT ID NCT03585465
First seen Jan 25, 2026 · Last updated May 11, 2026 · Updated 9 times
Summary
This study tests a combination of the immunotherapy drug nivolumab with low-dose chemotherapy in children and teenagers whose solid tumors have not responded to standard treatments. The goal is to see if the combo is safe and can help control the cancer longer. About 63 participants are expected, and the study is currently active but no longer recruiting.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHILDHOOD SOLID TUMOR are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Centre Léon Bérard (IHOPe)
Lyon, France
-
Centre Oscar Lambret
Lille, France
-
Cliniques Universitaires Saint-Luc (CUSL)
Brussels, Belgium
-
Hôpital La Timone, AP-HM
Marseille, France
-
Hôpital Mère-Enfant, CHU Nantes
Nantes, France
-
Hôpital d'Enfants - CHRU Nancy
Nancy, France
-
Hôpital de Hautepierre, CHRU Strasbourg
Strasbourg, France
-
Hôpital des Enfants - CHU Toulouse
Toulouse, France
-
Institut Curie
Paris, France
-
University Hospital Ghent
Ghent, Belgium
-
University Hospital Leuven
Leuven, Belgium
Conditions
Explore the condition pages connected to this study.